Alphatec Holdings, Inc. income statement
In fiscal 2025, Alphatec Holdings, Inc. reported revenue of $764m, up 25.0% on the year before, operating income of −$82.1m (a -10.7% margin) and net income of −$143m, or −$0.96 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.
Income statement
| Fiscal year | 2009Dec 2009 | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMSept 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 121 | 172 | 198 | 196 | 205 | 155 | 134 | 120 | 102 | 92 | 113 | 145 | 243 | 351 | 482 | 612 | 764 | 840 |
| Cost of revenue | 40 | 58 | 79 | 71 | 79 | 45 | 46 | 44 | 34 | 28 | 36 | 42 | 85 | 118 | 172 | 187 | 232 | 241 |
| Gross profit | 81 | 113 | 117 | 124 | 124 | 110 | 88 | 76 | 68 | 63 | 78 | 103 | 158 | 233 | 310 | 424 | 532 | 598 |
| Research and development | 13 | 16 | 17 | 15 | 14 | 17 | 18 | 9 | 5 | 10 | 14 | 19 | 32 | 44 | 70 | 81 | 76 | 76 |
| Selling, general and administrative | — | — | — | — | — | — | — | — | 70 | 73 | 102 | 129 | 229 | 300 | 374 | 450 | 499 | 532 |
| Selling and marketing | 49 | 67 | 75 | 75 | 77 | 56 | 52 | 51 | — | — | — | — | — | — | — | — | — | — |
| General and administrative | 19 | 31 | 36 | 40 | 48 | 34 | 28 | 26 | — | — | — | — | — | — | — | — | — | — |
| Operating income | −10 | −12 | −25 | −10 | −73 | 1 | −176 | −15 | −9 | −22 | −47 | −59 | −128 | −147 | −173 | −136 | −82 | −30 |
| Interest expense | 3 | 6 | 3 | 6 | 4 | 3 | 4 | 5 | — | — | 10 | 12 | 7 | 6 | 17 | 25 | 46 | 46 |
| Income before tax | −13 | −16 | −27 | −17 | −79 | 0 | −172 | −31 | −5 | −30 | −57 | −79 | −144 | −152 | −187 | −162 | −143 | −89 |
| Income tax | 0 | −2 | −5 | −1 | 3 | 0 | −1 | −5 | −0 | −1 | −0 | 0 | −1 | −1 | −0 | 0 | −0 | 2 |
| Net income | −13 | −14 | −22 | −15 | −82 | −13 | −179 | −30 | −2 | −29 | −57 | −79 | −143 | −151 | −187 | −162 | −143 | −87 |
| Diluted EPS | −$0.27 | −$2.16 | −$3.00 | −$2.04 | −$10.20 | −$1.90 | −$21.53 | −$3.49 | −$1.08 | −$1.20 | −$1.09 | −$1.18 | −$1.49 | −$1.46 | −$1.54 | −$1.13 | −$0.96 | −$0.56 |
| Diluted shares (average) | — | 7m | 7m | 8m | 8m | 8m | 8m | 9m | 13m | 35m | 52m | 67m | 96m | 103m | 121m | 143m | 150m | 155m |
| EBITDA | 2 | 5 | −5 | 14 | −47 | 20 | −157 | −3 | −2 | −16 | −40 | −48 | −101 | −106 | −117 | −58 | −5 | 39 |
| Quarter | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 | 2026 Q3Sept 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 177 | 169 | 186 | 197 | 213 | 192 | 214 | 221 |
| Cost of revenue | 55 | 53 | 56 | 59 | 63 | 56 | 59 | 63 |
| Gross profit | 122 | 116 | 129 | 137 | 149 | 136 | 154 | 158 |
| Research and development | 23 | 17 | 18 | 19 | 22 | 18 | 18 | 18 |
| Selling, general and administrative | 115 | 127 | 119 | 124 | 129 | 137 | 134 | 133 |
| Operating income | −24 | −44 | −13 | −16 | −9 | −23 | −2 | 3 |
| Interest expense | 7 | 8 | 12 | 13 | 13 | 12 | 11 | 11 |
| Income before tax | −33 | −52 | −41 | −29 | −22 | −34 | −26 | −7 |
| Income tax | 0 | −0 | −0 | 0 | −0 | 0 | 0 | 2 |
| Net income | −33 | −52 | −41 | −29 | −22 | −34 | −26 | −5 |
| Diluted EPS | −$0.23 | −$0.35 | −$0.27 | −$0.19 | −$0.15 | −$0.22 | −$0.16 | −$0.03 |
| EBITDA | −4 | −24 | 2 | −1 | 10 | −3 | 13 | 19 |
Compare with peers
- Orthofix Medical Inc. income statement
- Irhythm Holdings, Inc. income statement
- Varex Imaging Corp income statement
- Myriad Genetics Inc income statement
- Inspire Medical Systems, Inc. income statement
Head to head: ATEC vs OFIXATEC vs IRTCATEC vs VREXATEC vs MYGN
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies